Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 24475698)

1.

[Epigenetic research progress of anti-tumor drugs].

Liu MZ, He FZ, Zhang W.

Yao Xue Xue Bao. 2013 Nov;48(11):1629-36. Review. Chinese.

PMID:
24475698
2.

Epigenetic perspectives on cancer chemotherapy response.

Liu MZ, McLeod HL, He FZ, Chen XP, Zhou HH, Shu Y, Zhang W.

Pharmacogenomics. 2014 Apr;15(5):699-715. doi: 10.2217/pgs.14.41. Review.

PMID:
24798726
3.

Current and potential anticancer drugs targeting members of the UHRF1 complex including epigenetic modifiers.

Unoki M.

Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):116-30. Review.

PMID:
21110828
4.

Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.

Gerhauser C.

Top Curr Chem. 2013;329:73-132. doi: 10.1007/128_2012_360. Review.

PMID:
22955508
5.

Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer.

Khin SS, Kitazawa R, Kondo T, Idei Y, Fujimoto M, Haraguchi R, Mori K, Kitazawa S.

Cancers (Basel). 2011 Mar 3;3(1):982-93. doi: 10.3390/cancers3010982.

6.
7.

Towards targeted epigenetic therapy of cancer.

Magic Z, Supic G, Brankovic-Magic M.

J BUON. 2009 Sep;14 Suppl 1:S79-88. Review.

PMID:
19785074
8.

Epigenetic alteration and microRNA dysregulation in cancer.

Suzuki H, Maruyama R, Yamamoto E, Kai M.

Front Genet. 2013 Dec 3;4:258. doi: 10.3389/fgene.2013.00258. Review.

9.

Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.

Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H.

Cytotherapy. 2013 Sep;15(9):1164-73. doi: 10.1016/j.jcyt.2013.05.001. Epub 2013 Jun 22.

PMID:
23800731
10.

Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents.

Wang Y, Li Y, Liu X, Cho WC.

Curr Cancer Drug Targets. 2013 Jun;13(5):506-18. Review.

PMID:
23597195
11.
12.

Epigenetic cancer therapy: Proof of concept and remaining challenges.

Mund C, Lyko F.

Bioessays. 2010 Nov;32(11):949-57. doi: 10.1002/bies.201000061. Review.

PMID:
21154865
13.

Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer.

Jeong HM, Kwon MJ, Shin YK.

Front Oncol. 2014 Feb 4;4:12. doi: 10.3389/fonc.2014.00012. eCollection 2014. Review.

14.

Epigenetics and oncology.

Mummaneni P, Shord SS.

Pharmacotherapy. 2014 May;34(5):495-505. doi: 10.1002/phar.1408. Epub 2014 Mar 11. Review.

PMID:
24619798
15.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
16.

Use of epigenetic drugs in disease: an overview.

Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S.

Genet Epigenet. 2014 May 27;6:9-19. doi: 10.4137/GEG.S12270. eCollection 2014. Review.

17.

Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.

Wilting RH, Dannenberg JH.

Drug Resist Updat. 2012 Feb-Apr;15(1-2):21-38. doi: 10.1016/j.drup.2012.01.008. Epub 2012 Feb 20. Review.

18.

DNA methyltransferases as targets for cancer therapy.

Ghoshal K, Bai S.

Drugs Today (Barc). 2007 Jun;43(6):395-422. Review.

PMID:
17612710
19.
20.

Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport.

Zhong XB, Leeder JS.

Drug Metab Dispos. 2013 Oct;41(10):1721-4. doi: 10.1124/dmd.113.053942. Epub 2013 Aug 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk